Benyamin R, Trescot AM, Datta S, Buenaventura RM, Adlaka R, Sehgal N, et al. Opioid complications and side effects. Pain Physician. 2008;11:S105.
Aragón-Poce F, Martı́nez-Fernández E, Márquez-Espinós C, Pérez A, Mora R and Torres L. History of opium. in International Congress Series. Elsevier. 2002.
Goodrich JT. History of spine surgery in the ancient and medieval worlds. Neurosurg focus. 2004;16:1–13.
McDonald J, Lambert D. Opioid receptors. Contin Educ Anaesth Crit Care Pain. 2005;5:22–25.
Zhang JJ, Song CG, Dai JM, Li L, Yang XM, Chen ZN. Mechanism of opioid addiction and its intervention therapy: Focusing on the reward circuitry and mu‐opioid receptor. MedComm. 2022;3:e148.
Article ADS CAS PubMed PubMed Central Google Scholar
Madariaga-Mazón A, Marmolejo-Valencia AF, Li Y, Toll L, Houghten RA, Martinez-Mayorga K. Mu-Opioid receptor biased ligands: A safer and painless discovery of analgesics? Drug Discov today. 2017;22:1719–29.
Article PubMed PubMed Central Google Scholar
Rasmussen SG, DeVree BT, Zou Y, Kruse AC, Chung KY, Kobilka TS, et al. Crystal structure of the β2 adrenergic receptor–Gs protein complex. Nature. 2011;477:549–55.
Article ADS CAS PubMed PubMed Central Google Scholar
Watson H. Biological membranes. Essays Biochem. 2015;59:43–69.
Article PubMed PubMed Central Google Scholar
Manglik A, Kim TH, Masureel M, Altenbach C, Yang Z, Hilger D, et al. Structural insights into the dynamic process of β2-adrenergic receptor signaling. Cell. 2015;161:1101–11.
Article CAS PubMed PubMed Central Google Scholar
Chan HS, McCarthy D, Li J, Palczewski K, Yuan S. Designing safer analgesics via μ-opioid receptor pathways. Trends Pharmacol Sci. 2017;38:1016–37.
Article CAS PubMed PubMed Central Google Scholar
Trang T, Al-Hasani R, Salvemini D, Salter MW, Gutstein H, Cahill CM. Pain and poppies: The good, the bad, and the ugly of opioid analgesics. J Neurosci. 2015;35:13879–88.
Article CAS PubMed PubMed Central Google Scholar
Luttrell LM, Lefkowitz RJ. The role of β-arrestins in the termination and transduction of G-protein-coupled receptor signals. J Cell Sci. 2002;115:455–65.
Article CAS PubMed Google Scholar
Christie M. Cellular neuroadaptations to chronic opioids: tolerance, withdrawal and addiction. Br J Pharmacol. 2008;154:384–96.
Article CAS PubMed PubMed Central Google Scholar
Williams JT, Christie MJ, Manzoni O. Cellular and synaptic adaptations mediating opioid dependence. Physiol Rev. 2001;81:299–43.
Article CAS PubMed Google Scholar
Connor M, Osborne PB, Christie MJ. μ‐Opioid receptor desensitization: Is morphine different? Br J Pharmacol. 2004;143:685–96.
Article CAS PubMed PubMed Central Google Scholar
Bohn LM, Lefkowitz RJ, Gainetdinov RR, Peppel K, Caron MG, Lin F-T. Enhanced morphine analgesia in mice lacking β-arrestin 2. Science. 1999;286:2495–8.
Article CAS PubMed Google Scholar
Raehal KM, Walker JK, Bohn LM. Morphine side effects in β-arrestin 2 knockout mice. J Pharmacol Exp Ther. 2005;314:1195–201.
Article CAS PubMed Google Scholar
Bohn LM, Gainetdinov RR, Lin F-T, Lefkowitz RJ, Caron MG. μ-Opioid receptor desensitization by β-arrestin-2 determines morphine tolerance but not dependence. Nature. 2000;408:720–3.
Article ADS CAS PubMed Google Scholar
Hughes J, Smith T, Kosterlitz H, Fothergill LA, Morgan B, Morris H. Identification of two related pentapeptides from the brain with potent opiate agonist activity. Nature. 1975;258:577–9.
Article ADS CAS PubMed Google Scholar
Dhawan BN, Cesselin F, Raghubir R, Reisine T, Bradley P, Portoghese P, et al. International Union of Pharmacology. XII. Classification of opioid receptors. Pharmacol Rev. 1996;48:567–92.
Mogil JS, Grisel JE. Transgenic studies of pain. Pain. 1998;77:107–28.
Article CAS PubMed Google Scholar
Akil H, Owens C, Gutstein H, Taylor L, Curran E, Watson S. Endogenous opioids: Overview and current issues. Drug Alcohol Depend. 1998;51:127–40.
Article CAS PubMed Google Scholar
Wadenberg ML. A review of the properties of Spiradoline: A potent and selective k‐opioid receptor agonist. CNS Drug Rev. 2003;9:187–98.
Article CAS PubMed PubMed Central Google Scholar
Walsh SL, Strain EC, Abreu ME, Bigelow GE. Enadoline, a selective kappa opioid agonist: Comparison with butorphanol and hydromorphone in humans. Psychopharmacology. 2001;157:151–62.
Article CAS PubMed Google Scholar
Abbadie C, Abbadie GW. Endorphins and their receptors. In: Encyclopedia of the human brain. Elsevier; 2002. pp 193–200. https://doi.org/10.1016/B0-12-227210-2/00137-0.
El Daibani A, Che T. Spotlight on nociceptin/orphanin FQ receptor in the treatment of pain. Molecules. 2022;27:595.
Article CAS PubMed PubMed Central Google Scholar
Meunier J-C, Mollereau C, Toll L, Suaudeau C, Moisand C, Alvinerie P, et al. Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor. Nature. 1995;377:532–5.
Article ADS CAS PubMed Google Scholar
Reinscheid RK, Nothacker H-P, Bourson A, Ardati A, Henningsen RA, Bunzow JR, et al. Orphanin FQ: A neuropeptide that activates an opioidlike G protein-coupled receptor. Science. 1995;270:792–4.
Article ADS CAS PubMed Google Scholar
Mollereau C, Moisand C, Butour J-L, Parmentier M, Meunier J-C. Replacement of Gln280 by His in TM6 of the human ORL1 receptor increases affinity but reduces intrinsic activity of opioids. FEBS Lett. 1996;395:17–21.
Article CAS PubMed Google Scholar
Pan ZZ, Hirakawa N, Fields HL. A cellular mechanism for the bidirectional pain-modulating actions of orphanin FQ/nociceptin. Neuron. 2000;26:515–22.
Article CAS PubMed Google Scholar
Mollereau C, Simons M-J, Soularue P, Liners F, Vassart G, Meunier J-C, et al. Structure, tissue distribution, and chromosomal localization of the prepronociceptin gene. Proc Natl Acad Sci. 1996;93:8666–70.
Article ADS CAS PubMed PubMed Central Google Scholar
Nothacker H-P, Reinscheid RK, Mansour A, Henningsen RA, Ardati A, Monsma F Jr, et al. Primary structure and tissue distribution of the orphanin FQ precursor. Proc Natl Acad Sci. 1996;93:8677–82.
Article ADS CAS PubMed PubMed Central Google Scholar
Toll L, Bruchas MR, Cox BM, Zaveri NT. Nociceptin/orphanin FQ receptor structure, signaling, ligands, functions, and interactions with opioid systems. Pharmacol Rev 2016;68:419–57.
Article PubMed PubMed Central Google Scholar
Cox BM, Christie MJ, Devi L, Toll L, Traynor JR. Challenges for opioid receptor nomenclature: IUPHAR Review 9. Br J Pharmacol. 2015;172:317–23.
Article CAS PubMed Google Scholar
Paul AK, Smith CM, Rahmatullah M, Nissapatorn V, Wilairatana P, Spetea M, et al. Opioid analgesia and opioid-induced adverse effects: A review. Pharmaceuticals. 2021;14:1091.
Article CAS PubMed PubMed Central Google Scholar
Woolf CJ, et al., Towards a mechanism-based classification of pain? LWW 1998. 227–29.
Collett B. Opioid tolerance: the clinical perspective. Br J Anaesth. 1998;81:58–68.
Article CAS PubMed Google Scholar
Cepeda-Benito A, Davis KW, Reynoso JT, Harraid JH. Associative and behavioral tolerance to the analgesic effects of nicotine in rats: Tail-flick and paw-lick assays. Psychopharmacology. 2005;180:224–33.
留言 (0)